Distinct work‐related, clinical and psychological factors predict return to work following treatment in four different cancer types

Abstract

A different profile of predictive factors emerged for the four cancer types. In addition to optimal symptom management and workplace adaptations, the findings suggest that eliciting and challenging specific cancer and treatment-related perceptions may facilitate RTW.

Meaning of work and the process of returning after head and neck cancer

“…Other general problems were fatigue, dyspnea, teeth, trouble opening the mouth, coughing, and the need for painkillers. This implies a great coping ability because many of the patients returned to work despite these problems [18][19][20].…”

A Systematic Review of Outcomes after Revision Amputation for Treatment of Traumatic Finger Amputation

“…These extensive days off work may be as much a reflection on a patient's mental willingness as their physical readiness, and independent of treatment modality. [71][72][73] A total of 1430 digits were evaluated -151 thumbs and 462 index, 391 middle, 270 ring, and 156 little fingers. Noticeable gaps and variability in outcome reporting exists (Table 9), especially of PROs, hampering the possibility to generate an inclusive overview of non-replantation treatments.…”

Impact of Pain and Evaluation of Education and Self-Care in Patients with Head and Neck Cancer

“…At the time of diagnosis of HNC, 62% and 86%, respectively, were of working age [67,68]. Psychosocial factors and physical symptoms were the most common underlying reasons for sick leave among patients with HNC [67][68][69]. The time required for return to work following treatment varied significantly depending on tumour stage and symptoms [67,69].…”

“…Psychosocial factors and physical symptoms were the most common underlying reasons for sick leave among patients with HNC [67][68][69]. The time required for return to work following treatment varied significantly depending on tumour stage and symptoms [67,69]. Median duration of sick leave for patients with HNC was 22 weeks [67,69].…”

“…The time required for return to work following treatment varied significantly depending on tumour stage and symptoms [67,69]. Median duration of sick leave for patients with HNC was 22 weeks [67,69]. One Swedish study reported that 32 of 66 participating patients with HNC had returned to work 12 months after diagnosis [68].…”